Historical Stock Price
GENE historical stock prices picture
Genetic Technologies (GENE) has the following price history information. Looking back at GENE historical stock prices for the last five trading days, on April 12, 2024, GENE opened at $3.35, traded as high as $3.59 and as low as $3.20, and closed at $3.32. Trading volume was a total of 42.20K shares. On April 15, 2024, GENE opened at $3.38, traded as high as $3.38 and as low as $3.21, and closed at $3.27. Trading volume was a total of 15.80K shares. On April 16, 2024, GENE opened at $3.27, traded as high as $3.30 and as low as $3.05, and closed at $3.17. Trading volume was a total of 28.30K shares. On April 17, 2024, GENE opened at $3.28, traded as high as $3.28 and as low as $3.10, and closed at $3.16. Trading volume was a total of 13.50K shares. On April 18, 2024, GENE opened at $3.15, traded as high as $3.20 and as low as $2.30, and closed at $2.44. Trading volume was a total of 89.60K shares.

GENE Historical Stock Prices By Date:

GENE historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Genetic Technologies shares, starting with a $10,000 purchase of GENE, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/22/2014
End date: 04/18/2024
Start price/share: $143.00
End price/share: $2.44
Dividends collected/share: $0.00
Total return: -98.29%
Average Annual Total Return: -33.45%
Starting investment: $10,000.00
Ending investment: $170.59
Years: 10.00
Date Open High Low Close Volume
04/12/2024 $3.35 $3.59 $3.20 $3.32 42.20K
04/15/2024 $3.38 $3.38 $3.21 $3.27 15.80K
04/16/2024 $3.27 $3.30 $3.05 $3.17 28.30K
04/17/2024 $3.28 $3.28 $3.10 $3.16 13.50K
04/18/2024 $3.15 $3.20 $2.30 $2.44 89.60K
Genetic Technologies is a molecular diagnostics company that provides predictive testing and assessment tools to help physicians manage women's health. Co.'s key product, BREVAGenplus, was a clinically validated risk assessment test for non-hereditary breast cancer. Co. has launched the first generation BREVAGen test across the U.S. via its U.S. subsidiary Phenogen Sciences Inc. Co. has developed two new cancer risk assessment tests branded as GeneType for Colorectal Cancer and GeneType for Breast Cancer. Co. also develops other risk assessment tests across a range of diseases, including cardiovascular disease, type 2 diabetes, prostate cancer and melanoma.
Date Close
04/12/2024$3.32
04/15/2024$3.27
04/16/2024$3.17
04/17/2024$3.16
04/18/2024$2.44
GENE is categorized under the Healthcare sector; below are some other companies in the same sector:

GENT Historical Stock Prices
GERN Historical Stock Prices
GEVA Historical Stock Prices
GHDX Historical Stock Prices
GI Historical Stock Prices
GILD Historical Stock Prices
GIVN Historical Stock Prices
GKOS Historical Stock Prices
GLYC Historical Stock Prices
GMED Historical Stock Prices

Email EnvelopeFree GENE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


GENE Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.